• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 2 - Issue 2 - March/April 2005

Editor's Corner »

VDM Changes to a Double-Blind, Peer-Review Journal

By: Frank J. Criado, Editor-in-Chief

After reading this editorial, attentive VDM followers may find it somewhat contradictory with the “spirit and purpose” delineated in the initial Editor’s letter that accompanied the launch issue in October 2004. Regardless, change is in the air and we will not go back! VDM is going all peer-review, and will immediately adopt the journal format that everyone expects in such a publication.

The decision for change was based on multiple reasons. Important among many was the discovery that the scientific contributions received for publications after a short 3 or 4 months o

Read the full story »

Feature »

Endovascular Stent-Graft Repair of Dissection with Expanding Intramural Hematoma Following Renal Artery Stenting

By: Nicolas W. Shammas, MS, MD, Eric J. Dippel, MD, Karen E. Butler, RTR

Case Report: A 75-year-old male presented with recurrent episodes of flash pulmonary edema, angina, renal insufficiency (creatinine 2.1 mg/dl) and recurrent transient ischemic attacks. Diagnostic renal and coronary angiography revealed severe bilateral ostial calcific renal artery stenosis with mild disease in his left coronary system and a 60% ostial right coronary artery stenosis followed by an 80% lesion in the mid vessel. The left ventricular function by echocardiography was normal with an ejection fraction of 60%. Carotid ultrasound revealed a critical area of disease in the pro

Read the full story »

Commentary »

Endovascular Stent-Graft Repair of Renal Dissection with Expanding Intramural Hematoma Following Renal Artery Stenting

By: Richard Heuser, MD

Endovascular Stent-Graft Repair of Renal Dissection with Expanding Intramural Hematoma Following Renal Artery Stenting is an excellent case report, describing a fairly common problem treated in a unique way. Instead of just treating a subintimal dye leak at the site of stent overlap, Shammas et al. wisely analyzed the vessel lumen with intravascular ultrasound, showing that there was an intramural hematoma. The conservative approach paid off with effective therapy, without placement of further stents that may have jeopardized one or two important renal branches supplying the renal paren

Read the full story »

Feature »

Clinical Outcome Following Renal Artery Stenting for Renovascular Hypertension in Patients (see full title below)

By: Sandeep Kholsa, MD, Vasundhara Vidyarthi, MD, Aziz Ahmed, MD, Atul Trivedi, MD, Daniel Benatar, MD

FULL TITLE: Clinical Outcome Following Renal Artery Stenting for Renovascular Hypertension in Patients Presenting with Angina or Heart Failure

Part of this data was presented as a poster abstract at the Annual Scientific Sessions of The Society for Cardiac Angiography and Interventions in 2002.

Abstract
Renal artery stenosis results in Renin-Angiotensin-Aldosterone mediated hypertension and volume overload. This is unfavorable in patients with angina or heart failure. To evaluate the effect of renal artery stenting in patients with renovascular hypertension prese

Read the full story »

Feature »

Propaedeutical Endovascular Interventions in High-Risk Candidates for Coronary Surgery

By: 1Gianluca Rigatelli, MD, Loris Roncon, MD, Emiliano Bedendo, RT, Massimo Giordan, MD, Massimo Rinuncini, MD, Tranuillo Milan, RN, 2Mario Zanchetta, MD, 1Pietro Zonzin, MD, 3Giorgio Rigatelli, MD

ABSTRACT: Purpose. Peripheral vascular disease (PVD) is a major risk factor in candidates for coronary surgery, impacting the overall mortality and morbidity in the preoperative time and follow-up after coronary surgery. High-risk patients with PVD may benefit from endovascular treatment prior to coronary surgery. We sought to identify, in high-risk patients, the most frequent clinical settings requiring propaedeutical endovascular treatment before coronary surgery, the results, and the mid-term impact on subsequent surgical revascularization. Methods. Between November 2002 and Novemb

Read the full story »

Feature »

Strategies to Optimize Percutaneous Coronary Intervention Outcomes in Diabetics

By: Umesh K. Arora, MD and Meeney Dhir, MD

Diabetes is a major public health problem. The incidence of diabetes among adults in the United States is increasing at epidemic proportions, with almost half of the U.S. states reporting a 6% incidence of diabetes mellitus. The prevalence of diabetes increases with age in both men and women. It peaks by 75 years of age when 21% of men and 17.5% of women have diabetes.1

Coronary artery disease (CAD) is the most frequent cardiovascular complication of diabetes. It occurs 2–3 times more often in patients with diabetes than in those without diabetes.2 Patients with diab

Read the full story »

Feature »

Dynamic Anatomy of the Popliteal Artery: Hinge Point and Accessory Flexions

By: 1Jose A. Diaz, MD, 2Marisa H. Miceli, MD, 1Miguel Villegas, MD, Gustavo Tamashiro, MD, Alberto Tamashiro, MD

EDITOR’S NOTE: This article by Diaz et al. contains extremely valuable information. The importance of assessing the “dynamic anatomy” of the popliteal artery (and other vessels) was only recently appreciated as a result of developments with endovascular therapy and the increasing use of fracture-prone intraluminal metallic stents. The findings described by the Argentinian group should prove useful to interventionalists who are planning to perform a stenting procedure in a given patient. But even more so, they will likely have an impact on current R&D efforts and concepts surrou

Read the full story »

Feature »

Extra-Coronary Pressure Gradient Assessment: Use of the pressure wire in peripheral, valvular, and congenital heart disease

By: Ted Feldman, MD

The measurement of translesional pressure gradients was an integral part of the development of coronary angioplasty. Gruentzig demonstrated a relationship between post-PTCA translesional gradient and the occurrence of both early complications and late restenosis in the 1980s.1 At that time, only fluid-filled catheter systems were used, and were limited by their bulk, lack of fidelity, and pressure damping in small catheter lumens. Intracoronary gradient assessment has been repopularized by the availability of 0.014” guidewire mounted pressure sensors. These devices have been avail

Read the full story »

Feature »

Online Training for Carotid Stenting Professionals

By: William Gray, MD, FACC

This online Carotid Education and Stenting Course was developed with four key physician consultants — an interventional cardiologist, a neurosurgeon, an interventional radiologist and a vascular surgeon. Why was it important to take a cross-specialty approach in developing the modules in this program?

Carotid artery stenting is unique in that it is a procedure performed by multiple specialties, each bringing a specific skill set and cognitive features into play. The challenge is to funnel these varying areas of expertise down to a common entry point and provide a pathway for CAS

Read the full story »

Interview »

The 13th Annual Global Cardiovascular Interventions–New Devices Seminar

By: Vascular Disease Management talks with two of the directors for the New Devices Seminar, Dr. Mark H. Wholey and Dr. Jay S. Yadav

Dr. Mark H. Wholey

What would you like to share with the physician or professional who has never had the chance to attend the New Devices Seminar?
The New Devices Seminar is a meeting we have had for approximately 12 years now, on an annual basis. It is designed for physicians interested in peripheral vascular disease, but also coronary artery disease as well.
A blue-ribbon faculty presents cases and discusses concepts in management of complex and simple cases. With the expansion of interest from cardiologists and vascular surgeons in endovascular peripheral procedures, it

Read the full story »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications